Gyrus Capital Leads $68M Equity Investment in Neo Medical

Gyrus Capital Acquires LRE Medical

August 1, 2023

Medical Devices

Gyrus Capital, a Geneva-based investment firm, has acquired LRE Medical, a Germany-headquartered maker of complex diagnostic devices and analytical instruments, from AIS Global (previously a KPS-backed business). LRE Medical (founded 1961) operates two sites in Germany with more than 250 employees; the transaction—a carve-out/buyout—closed in August 2023 and is intended to accelerate growth in point-of-care diagnostics.

Gyrus Capital Acquires 40% Stake in Consulcesi Group

December 1, 2022

Healthcare Services

Funds advised by Gyrus Capital have acquired a 40% stake in Consulcesi Group, with founder Massimo Tortorella and management remaining involved. The investment will support Consulcesi's international expansion and M&A-driven growth to build a pan‑European digital healthcare platform and target doubling revenue to over €120 million by 2025.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

ATL Technology Acquires Manufacturing Operations of Gyrus Medical Limited

April 24, 2023

Medical Devices

ATL Technology has acquired the manufacturing operations of Gyrus Medical Limited in Cardiff from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). The deal expands ATL's European manufacturing footprint and engineering capabilities to support medical device OEM customers.

PSG Leads $47M Growth Investment in Nym

October 1, 2024

Healthcare Services

Nym, a New York–based developer of an autonomous medical coding engine, raised $47 million in growth capital led by PSG with participation from GV (Google Ventures), Addition, Samsung Next, Dynamic Loop Capital and existing investors. The funding will accelerate expansion of Nym’s multi-specialty autonomous coding solution across new care areas and scale its AI-driven revenue cycle management offering for health systems, hospitals and physician groups.

Gyrus Capital Acquires Majority Stake in Katalist Group

June 24, 2022

IT Services

Gyrus Capital has agreed with Katalist Group founders and management to acquire a majority stake in Katalist Group to build a global software integration platform serving food wholesalers/retailers and pharmacy companies. Katalist — a software implementation and consulting specialist with more than 300 employees operating across Europe, Asia and the Americas — will pursue growth through further acquisitions and integration of specialist software implementors.